The Braun Group celebrates the award of its first patent! “Biomarkers of endogenous biological time”, US Patent 11,328,790, provides a method for inferring human circadian phase from blood gene expression profiles.
The Braun Group celebrates the award of its first patent! “Biomarkers of endogenous biological time”, US Patent 11,328,790, provides a method for inferring human circadian phase from blood gene expression profiles.
